Essex Bio-Technology Executes Targeted Buyback of 9,000 Shares, Slightly Lifts Treasury Stock

Bulletin Express09-14

On 14 September 2026, Essex Bio-Technology Limited repurchased 9,000 ordinary shares on the Hong Kong Stock Exchange at prices ranging from HKD 2.03 to HKD 2.05, for a volume-weighted average cost of HKD 2.0361 per share. The aggregate consideration amounted to HKD 0.02 million.

Following the transaction, the number of issued shares excluding treasury stock fell by 0.00159% to 564.96 million, while treasury shares increased to 2.04 million. Total issued shares remained unchanged at 567.01 million.

The buyback was conducted under the repurchase mandate approved on 26 May 2026, which authorizes the company to repurchase up to 56.70 million shares. Cumulative repurchases under this mandate now total 2.04 million shares, representing 0.36% of the issued share capital on the mandate’s approval date. In accordance with Hong Kong listing rules, a 30-day moratorium on new share issues or sales of treasury shares extends through 14 October 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1187931072?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-14 17:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1187931072","market":"us","top_or_hot":-1,"title":"Essex Bio-Technology Executes Targeted Buyback of 9,000 Shares, Slightly Lifts Treasury Stock","media":"Bulletin Express","content":"<p>On 14 September 2026, Essex Bio-Technology Limited repurchased 9,000 ordinary shares on the Hong Kong Stock Exchange at prices ranging from HKD 2.03 to HKD 2.05, for a volume-weighted average cost of HKD 2.0361 per share. The aggregate consideration amounted to HKD 0.02 million.</p>\n<p>Following the transaction, the number of issued shares excluding treasury stock fell by 0.00159% to 564.96 million, while treasury shares increased to 2.04 million. Total issued shares remained unchanged at 567.01 million.</p>\n<p>The buyback was conducted under the repurchase mandate approved on 26 May 2026, which authorizes the company to repurchase up to 56.70 million shares. Cumulative repurchases under this mandate now total 2.04 million shares, representing 0.36% of the issued share capital on the mandate’s approval date. In accordance with Hong Kong listing rules, a 30-day moratorium on new share issues or sales of treasury shares extends through 14 October 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Essex Bio-Technology Executes Targeted Buyback of 9,000 Shares, Slightly Lifts Treasury Stock</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEssex Bio-Technology Executes Targeted Buyback of 9,000 Shares, Slightly Lifts Treasury Stock\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-09-14 17:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>On 14 September 2026, Essex Bio-Technology Limited repurchased 9,000 ordinary shares on the Hong Kong Stock Exchange at prices ranging from HKD 2.03 to HKD 2.05, for a volume-weighted average cost of HKD 2.0361 per share. The aggregate consideration amounted to HKD 0.02 million.</p>\n<p>Following the transaction, the number of issued shares excluding treasury stock fell by 0.00159% to 564.96 million, while treasury shares increased to 2.04 million. Total issued shares remained unchanged at 567.01 million.</p>\n<p>The buyback was conducted under the repurchase mandate approved on 26 May 2026, which authorizes the company to repurchase up to 56.70 million shares. Cumulative repurchases under this mandate now total 2.04 million shares, representing 0.36% of the issued share capital on the mandate’s approval date. In accordance with Hong Kong listing rules, a 30-day moratorium on new share issues or sales of treasury shares extends through 14 October 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01061","symbol_name":"亿胜生物科技","start_time":0,"source_url":"","article_id":"1187931072","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1187931072","pubTimestamp":1789376638,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"On 14 September 2026, Essex Bio-Technology Limited repurchased 9,000 ordinary shares on the Hong Kong Stock Exchange at prices ranging from HKD 2.03 to HKD 2.05, for a volume-weighted average cost of...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01061":"亿胜生物科技"},"translate_title":"Essex Bio-Technology 定向回购 9,000 股股票，略微增加库存","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01061":1},"content_text":"On 14 September 2026, Essex Bio-Technology Limited repurchased 9,000 ordinary shares on the Hong Kong Stock Exchange at prices ranging from HKD 2.03 to HKD 2.05, for a volume-weighted average cost of HKD 2.0361 per share. The aggregate consideration amounted to HKD 0.02 million.\nFollowing the transaction, the number of issued shares excluding treasury stock fell by 0.00159% to 564.96 million, while treasury shares increased to 2.04 million. Total issued shares remained unchanged at 567.01 million.\nThe buyback was conducted under the repurchase mandate approved on 26 May 2026, which authorizes the company to repurchase up to 56.70 million shares. Cumulative repurchases under this mandate now total 2.04 million shares, representing 0.36% of the issued share capital on the mandate’s approval date. In accordance with Hong Kong listing rules, a 30-day moratorium on new share issues or sales of treasury shares extends through 14 October 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1187931072","isCrawlerRequest":true}